Pelvital raises $2.3m to advance commercialisation of Flyte device
Pelvital’s Flyte device is approved by the US FDA to treat stress urinary incontinence (SUI) and weakened pelvic floor muscles.
Pelvital’s Flyte device is approved by the US FDA to treat stress urinary incontinence (SUI) and weakened pelvic floor muscles.
The observational study will assess the clinical and workflow benefits of using Hyperfine’s Swoop system in detecting amyloid abnormalities in Alzheimer’s patients.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
MMI secures FDA approval for Symani Surgical System
Cleerly touts new data for AI cardiovascular software
Avicenna.AI wins two FDA clearances for AI tools in CT scans